Pricing of drugs and donations: options for sustainable equity pricing.
AffiliationCampaign for Access to Essential Medicines, Médecins sans Frontières, Geneva, Switzerland. email@example.com
MetadataShow full item record
AbstractEffective medicines exist to treat or alleviate many diseases which predominate in the developing world and cause high mortality and morbidity rates. Price should not be an obstacle preventing access to these medicines. Increasingly, drug donations have been established by drug companies, but these are often limited in time, place or use. Measures exist which are more sustainable and will have a greater positive impact on people's health. Principally, these are encouraging generic competition; adopting into national legislation and implementing TRIPS safeguards to gain access to cheaper sources of drugs; differential pricing; creating high volume or high demand through global and regional procurement; and supporting the production of quality generic drugs by developing countries through voluntary licenses if needed, and facilitating technology transfer.
- A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime.
- Authors: Weber A, Mills L
- Issue date: 2010 Jun 15
- Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?
- Authors: Dionisio D, Cao Y, Hongzhou L, Kraisintu K, Messeri D
- Issue date: 2006 Jan
- Differential pricing for pharmaceuticals: reconciling access, R&D and patents.
- Authors: Danzon PM, Towse A
- Issue date: 2003 Sep
- Trends and economic stress: a challenge to universal access to antiretroviral treatment in India.
- Authors: Dhamija P, Bansal D, Medhi B
- Issue date: 2009 Jul
- Companies reduce prices for HIV drugs in developing countries.
- Authors: Gottlieb S
- Issue date: 2000